Eric Loumeau

2018

In 2018, Eric Loumeau earned a total compensation of $2.2M as General Counsel at ANAPTYSBIO.

Compensation breakdown

Non-Equity Incentive Plan$54,763
Option Awards$1,961,388
Salary$148,106
Other$774
Total$2,165,031

Loumeau received $2M in option awards, accounting for 91% of the total pay in 2018.

Loumeau also received $54.8K in non-equity incentive plan, $148.1K in salary and $774 in other compensation.

Rankings

In 2018, Eric Loumeau's compensation ranked 5,315th out of 14,244 executives tracked by ExecPay. In other words, Loumeau earned more than 62.7% of executives.

ClassificationRankingPercentile
All
5,315
out of 14,244
63rd
Division
Manufacturing
2,007
out of 5,759
65th
Major group
Chemicals And Allied Products
734
out of 2,122
65th
Industry group
Drugs
614
out of 1,811
66th
Industry
Pharmaceutical Preparations
474
out of 1,385
66th
Source: SEC filing on April 26, 2019.

Loumeau's colleagues

We found three more compensation records of executives who worked with Eric Loumeau at ANAPTYSBIO in 2018.

2018

Hamza Suria

ANAPTYSBIO

Chief Executive Officer

2018

Marco Londei

ANAPTYSBIO

Chief Medical Officer

2018

Dominic Piscitelli

ANAPTYSBIO

Chief Financial Officer

News

In-depth

You may also like